Temporomandibular Disorder in Use of Levonorgestrel Intrauterine System
Is the Incidence of Temporomandibular Disorder Increased in the Use of Levonorgestrel Intrauterine System
Marmara University
100 participants
Jan 15, 2024
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to investigate the possible role of levonorgestrel intrauterine system use(LIU) in the pathogenesis of temporomandibular joint disorder (TMD). In this clinical trial, levonorgestrel intrauterine system patients (n=30) aged 25-50 and control group patients (n=30) with the same demographics and age range are used. The main questions it aims to answer are: To compare the frequency of temporomandibular dysfunction in women using the levonorgestrel intrauterine system with the control group of the same demographic and age range. The levonorgestrel intrauterine system use group consisted of 50 women who had previously a mirena implanted by a gynecologist at least 3 months ago due to menstrual bleeding and pelvic pain. The control group included 50 randomised healthy women who had regular menstrual cycles and were not taking any medication.
Eligibility
Inclusion Criteria4
- Being a woman
- Having used an intrauterine device for at least 3 months
- Being between the ages of 18-50
- Being in American Society of Anesthesiologists-1 and American Society of Anesthesiologists-2 systemic status
Exclusion Criteria6
- Patients with craniofacial syndrome
- Patients with a history of head and neck trauma
- Isolated muscle tenderness or previous surgery on TMJ
- Patients with rheumatological disorders
- Patients with an additional gynecological disease other than endometriosis
- Lack of cooperation with the patient.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The TMJ and the masticatory muscles were evaluated by the same clinician. Patients described symptoms such as preauricular pain, limited mouth opening, deviation or deflection during mouth opening, and joint sounds. All patients were assessed using Okeson's Muscle and temporomandibular joint examination and treatment outcome form. This form records (for both TMJ) tenderness and pain in the masseter, temporalis, lateral pterygoid, medial pterygoid, sternocleidomastoid, trapezius, splenius capitis, and digastric muscles, as well as maximum interincisal distance, restriction of laterotrusion and protrusive movements, joint sounds, deviation or deflection during mouth opening, and the visual analogue score (VAS) for pain in the TMJ.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06500390